Argent Trust Co’s Teva Pharmaceuticals TEVA Stock Holding History

Argent Trust Co’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,781	Closed	-$248K	–	254
2015 Q4	$248K	Buy	+3,781	New	+$234K	0.12%	203

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Argent Trust Co's TEVA Position: Q1 2016 in Review

Argent Trust Co sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 3,781 shares — an estimated $248K sold.

Argent Trust Co first reported a position in TEVA in Q4 2015 and held it in 1 quarter. The position peaked at $248K in Q4 2015. 836 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Argent Trust Co reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Argent Trust Co sold 3,781 Teva Pharmaceuticals shares in Q1 2016, an estimated $248K.
Argent Trust Co first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 1 quarter.
Argent Trust Co's Teva Pharmaceuticals position peaked at $248K in Q4 2015.
836 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Argent Trust Co's 13F filing for Q1 2016, filed 10 May 2016.